SLNO
Soleno Therapeutics·NASDAQ
--
--(--)
--
--(--)
SLNO Filings
Filing Date
Form Description
Form Type
2026-03-27
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-27 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-03-16
Form 8-K - Current report
Key Events
2026-03-16 · Key Events
Form 8-K - Current report
2026-03-04
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-04 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-04
Form 3 - Initial statement of beneficial ownership of securities
Ownership
2026-03-04 · Ownership
Form 3 - Initial statement of beneficial ownership of securities
2026-02-26
Form 8-K - Current report
Key Events
2026-02-26 · Key Events
Form 8-K - Current report
2026-02-25
Soleno Therapeutics, Inc. (SLNO) Q4 2025 Earnings Call Transcript
Earnings Call
2026-02-25 · Earnings Call
Soleno Therapeutics, Inc. (SLNO) Q4 2025 Earnings Call Transcript
2026-02-25
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-02-25 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-02-25
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-02-25 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-25
Form 8-K - Current report
Key Events
2026-02-25 · Key Events
Form 8-K - Current report
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
